KEY TAKEAWAYS The study aimed to explore a precision therapy strategy for pts with TNBC. The Fluorouracil-modified AS1411-paclitaxel conjugates showed promising TNBC targeting and synergistic antitumor effects, needing translational investigations. Triple-negative...